However, LYCO administered post-IBD significantly (p < 0.01) (n = 6) reduced mean colonic MPO from 6907.45 ± 1007.17 (no LYCO) to 2071.17 ± 271.16 ng/mg of protein and from 5890.60 ± 1438.66 (no LYCO) to 1471.43 ± 390.88 ng/mg of protein at 2 and 4 days of IBD, respectively. Here, MPO is linked to inflammatory bowel disease.